- 积分
- 136
- 威望
- 136
- 包包
- 97
|
看大家对menstrual blood这么感兴趣,我又特意将美国Cryocell公司的collection kit 找出来给大家看看,满足一下大家的好奇心。目前Cryocell的这个专利技术已经应用于市场,在中国是授权杭州一家公司在做储存,在印度是授权lifecell公司在做。* L5 W- R7 U& t
+ R y, A8 {& Z M4 \8 z
; u, {6 K( h" |' x6 V采集套装的介绍:
+ x# Z# o8 ^6 W- ? Q. E L% EInside, you’ll find everything needed for you to collect and send your C’elle menstrual stem cells for processing and preservation, including a menstrual cup, collection tubes, prepaid FedEx airbill for return shipment to Cryo-Cell, and comprehensive instructions for use.
& K4 b" z* E; C% W$ U; rThe new service, called C’ellesm (pronounced “C-L”), enables women to collect menstrual flow containing stem cells, which can be cryogenically preserved in a manner similar to stem cells from umbilical cord blood and may one day serve as a potential source for promising regenerative therapies to treat heart disease, diabetes, neurological disorders like spinal cord injury, Parkinson’s and Alzheimer’s diseases, in addition to cosmeceutical applications such as anti-aging therapies, to name a few. However, realistically, it may take several years for these menstrual stem cells to be developed into potential widely-available commercial therapies. The C’elle service is based on Cryo-Cell’s intellectual property, for which patent applications are pending, related to the procurement, processing, isolation and cryo-preservation of these unique menstrual stem cells.
# I! W8 @' d) q3 ]1 `The unique C’elle service is being offered following Cryo-Cell’s discovery of new scientific evidence that menstrual flow, which results from the shedding of the uterine lining (endometrium) during menstruation, contains millions of stem cells that have many properties and characteristics similar to those of both bone marrow and embryonic stem cells. Dr. Amit N. Patel, Director of Cardiac Stem Cell Therapies at the McGowan Institute, University of Pittsburgh Medical Center, along with other independent research laboratories, studied these menstrual stem cells, which have demonstrated the capability in vitro to differentiate into neural, cardiac, bone, cartilage, and adipose cells, and possibly other cell types. Dr. Patel’s preliminary findings were presented on October 21, 2007 at TCT 2007, the annual scientific symposia of Transcatheter Cardiovascular Therapeutics, in a seminar entitled “Novel Cell Sources for Myocyte Repair and Replacement”. ( I4 D5 R; r" O& h) x6 M
: c5 j# q! e. Y! R: b r |
附件: 你需要登录才可以下载或查看附件。没有帐号?注册
-
总评分: 威望 + 5
包包 + 10
查看全部评分
|